Gheorghe Doros, PhD
Professor
Boston University School of Public Health
Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest
BS, University of Bucharest



Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Member
Boston University
BU-BMC Cancer Center


Boston Medical Center




Screening for AL Amyloidosis in Smoldering Multiple Myeloma
03/01/2024 - 02/29/2028 (Subcontract PI)
Tufts Medical Center, Inc. NIH NCI
1R01CA279808-01A1

Biostatisics VA Support - Doros Group
08/26/2021 - 08/25/2026 (PI)
Department of Veterans Administration


Mechanistic underpinnings of increased adipose tissue in HFpEF
07/01/2019 - 06/30/2025 (Key Person)
PI: Flora Sam, MD
NIH/National Heart, Lung, and Blood Institute
5R01HL145985-04

BAIM Institute Student Suppport - Doros Group - for Luke Zheng
09/01/2023 - 09/01/2024 (PI)
Baim Institute for Clinical Research


General support for clinical studies at Baim Institute
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


BAIM Institute Student Suppport - Doros Group - for Daniel Kojis
09/01/2023 - 08/31/2024 (PI)
Baim Institute for Clinical Research


Gheorghe Doros, PhD: Statistical research in clinical trials (Baim Institute for Clinical Research)
09/01/2017 - 08/31/2023 (PI)
Baim Institute for Clinical Research


VA241-16-D-0012 VA Master Contract Task Order 24
09/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System


VA241-16-D-0012 VA Master Contract Task Order 19 (Luke Zheng)
05/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System


VA241-16-D-0012 VA Master Contract Task Order 18
09/01/2019 - 08/31/2020 (PI)
VA Boston Healthcare System


Showing 10 of 19 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL. Advanced Wound, Ischemia, and foot Infection stage is associated with poor outcomes in the BEST-CLI trial. J Vasc Surg. 2024 Dec 03.View Related Profiles. PMID: 39638100
     
  2. McGinigle KL, Doros G, Alabi O, Brooke BS, Vouyouka A, Hiramoto J, Charlton-Ouw K, Strong MB, Rosenfield K, Menard MT, Farber A, Giles KA. Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial. J Vasc Surg. 2024 Oct 04.View Related Profiles. PMID: 39368637
     
  3. Ochoa Chaar CI, Malas M, Doros G, Schermerhorn M, Conte MS, Alameddine D, Siracuse JJ, Yadavalli SD, Dake MD, Creager MA, Tan TW, Rosenfield K, Menard MT, Farber A, Hamdan A. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Sep 25.View Related Profiles. PMID: 39332785
     
  4. Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2024 Sep 23.View Related Profiles. PMID: 39321895
     
  5. Caliskan E, Misfeld M, Sandner S, Böning A, Aramendi J, Salzberg SP, Choi YH, Perrault LP, Tekin I, Cuerpo GP, Lopez-Menendez J, Weltert LP, Böhm J, Krane M, González-Santos JM, Tellez JC, Holubec T, Ferrari E, Doros G, Emmert MY. Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry. Front Cardiovasc Med. 2024; 11:1366460. PMID: 39346099; PMCID: PMC11428045; DOI: 10.3389/fcvm.2024.1366460;
     
  6. Verma K, Staron A, Zheng L, Cetin O, Doros G, Sanchorawala V. Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):869-872.View Related Profiles. PMID: 39214751
     
  7. Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, Kayssi A, Schneider PA, Hawkins BM, Dake MD, Hamza T, Strong MB, Rosenfield K, Conte MS. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial. J Vasc Surg. 2024 Dec; 80(6):1755-1765.e4.View Related Profiles. PMID: 39069016
     
  8. Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, Goodney PP, Abou-Zamzam AM, Motaganahalli R, Doros G, Creager MA. Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024 Nov; 68(5):590-597.View Related Profiles. PMID: 38925339
     
  9. Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong MB, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions. J Vasc Surg. 2024 Nov; 80(5):1515-1524.View Related Profiles. PMID: 38908805; PMCID: PMC11633720; DOI: 10.1016/j.jvs.2024.05.049;
     
  10. Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Sep; 80(3):774-779.View Related Profiles. PMID: 38626847
     
Showing 10 of 355 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 355 publications over 22 distinct years, with a maximum of 41 publications in 2014

YearPublications
20031
20041
20051
20063
20077
20084
200914
201014
201115
20129
201321
201441
201539
201628
201739
201836
201922
202010
202114
202214
20239
202413


For COVID-19 Patients, Could Breathing Easier Be as Simple as Flipping Over?

Mirage News 4/18/2020

Medtronic data show no paclitaxel-mortality link amid FDA warnings

MedTech Dive 1/23/2019

Patient-level survival analysis demonstrates no link between paclitaxel dose and mortality in patients treated with IN.PACT Admiral DCB

Vascular News 1/22/2019

Medical Campus Sees Eight New Full Professorships

BU Today 3/8/2018

2008-2010 Boston University School of Public Health: Excellence in Teaching Award
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.638.5871
Download vCard

Doros's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (826) concept(s)
_
Media Mentions
_
Co-Authors
See all (98) people
_
Similar People
See all (60) people
_
Same Department
Search Department